Baylor Research Institute

Programs: See schedule oheadquartered in dallas, texas, baylor research institute dba baylor scott & white research institute (bsw research) is responsible for the oversight and management of all bench and clinical research conducted throughout the baylor scott & white health (bswh) system. Established in 1984, our mission is to improve the care and well-being of our community, nationally and internationally, through innovative research that is consistent with the mission, vision and values of baylor scott & white health. We are a research center dedicated to advancing healthcare and ultimately, patient care, through the study and discovery of new preventive therapies and treatments for a broad spectrum of diseases, and other chronic patient conditions. This means our efforts are more than microscopic studies; they bring research to the patient's bedside. We focus on understanding the base of a disease, in order to then identify potential treatments or preventive therapies, and enroll patients in research trials to further test and / or validate each theory. Bsw research has approximately 400 employees, including scientists, phds, laboratory assistants, and research coordinators, who are located throughout bswh. The results of the institute's research for basic science, translational, and clinical studies are reported in major scientific publications and at national and international medical meetings. Currently, more than 2,000 research studies are under way. The following is a brief snapshot of select research centers and institutes operating under bsw research in north texas. Baylor institute for immunology research (biir) focuses on the study of the immune system in oncology, infectious and autoimmune disease, and transplantation. Also, the institute is dedicated to moving new treatments from the bench to the bedside as efficiently as possible. In january of 2012, biir dedicated the ralph steinman center for cancer vaccines after the late nobel prize-winning physician who first observed what would become known as a dendritic cell. Today, vaccines using dendritic cells and immunotherapies are viable treatments for many diseases from hiv to cancer. Scientific inquiry into relatively rare medical disorders often results in a better understanding of common diseases and leads to new therapies. The goal of the kimberly h. Courtwright and joseph w. Summers institute of metabolic disease (imd) is to find innovative ways of diagnosing, understanding and treating rare or common disease caused by inborn errors of the metabolism hindering the body's production of energy from dietary protein, fats and carbohydrates. Imd develops diagnostics and therapeutics that harness the complementary fields of metabolomics and metabolic disease. Since imd's founding in 1988, its scientists have identified five previously unknown diseases and devised new treatment protocols for a number of inherited metabolic disorders. Imd has developed the know-how and expertise to make significant strides, as evidenced by the discovery and development of novel diagnostics and therapeutics in a large number of disease indications. The baylor annette c. And harold c. Simmons transplant institute was founded in 1984 to successfully integrate clinical medical research into transplantation medicine for rapid application to patients. Since then, more than 11,000 organ transplants, as well as more than 5,000 blood and marrow transplants, have been performed at baylor university medical center and baylor scott & white all saints medical center - fort worth. The program includes kidney, pancreas, liver, heart, lung, as well as islet cell transplants for the treatment of type 1 diabetes. The hallmark of the transplant institute is human tissue research and its unique biorepository containing a wealth of information collected over decades from thousands of bswh patients receiving liver transplants. This year, the transplant program reached a major milestone and research first, after performing a living-donor uterine transplant, which resulted in the first uterine transplant pregnancy in the united states. The institute for healthcare research and improvement (ihcri) was established in 1999, and with the 2013 merger of bswh, the ihcri was reconfigured into the office of the chief quality officer (cqo). The office of the chief quality officer improves the quality of healthcare across baylor scott & white health in alignment with the institute of medicine's call for healthcare to become more steeep (safe, timely, effective, efficient, equitable, and patient centered). The cqo collaborates with researchers at the local, state and national level and is involved in multi-site research networks, including the agency for healthcare research and quality (ahrq)-sponsored accelerating change and transformation in organizations and networks.